AI assistant
BIO-TECHNE Corp — Director's Dealing 2022
Aug 17, 2022
30718_dirs_2022-08-17_063b57d7-2015-49d3-911d-5eec2e1fdcf3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-08-15
Reporting Person: Hippel James (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-15 | Restricted Stock Units | $ | A | 2728 | Acquired | Common Stock (2728) | Direct | |
| 2022-08-15 | Stock Options (Right to Buy) | $378.08 | A | 8479 | Acquired | 2029-08-15 | Common Stock (8479) | Direct |
| 2022-08-15 | Stock Options (Right to Buy) | $378.08 | A | 11305 | Acquired | 2029-08-15 | Common Stock (11305) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 12755 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (47389) | 47389 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (18066) | 18066 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (24089) | 24089 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (19936) | 19936 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (26581) | 26581 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (14360) | 14360 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (19147) | 19147 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Stock Options (Right to Buy) | $267.87 | 2027-08-05 | Common Stock (8325) | 8325 | Direct |
| Restricted Stock Units | $ | Common Stock (1945) | 1945 | Direct | |
| Stock Options (Right to Buy) | $481.82 | 2028-08-06 | Common Stock (7600) | 7600 | Direct |
| Stock Options (Right to Buy) | $481.82 | 2028-08-06 | Common Stock (10134) | 10134 | Direct |
| Restricted Stock Units | $ | Common Stock (3219) | 3219 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F2: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F3: Options to purchase 2,826 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026 and options to purchase 2,827 shares vest on 8/15/2024.
F4: Fully exercisable.
F5: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later ate as performance is certified by the Administrator).
F6: Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/22 and 8/7/2023.
F7: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Option to purchase 4,787 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023 and options to purchase 4,786 shares vest on 8/5/2024.
F9: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F10: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F11: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12: Options to purchase 2,534 shares vests on each of 8/6/2022 and 8/6/2023 and options to purchase 2,533 shares vests on each of 8/6/2024 and 8/6/2025.